Correlia Biosystems went through Y Combinator in the Winter 2018 batch and describes itself as: Next-gen blood testing to provide 1000x more data to pharma companies. As of November 10, 2026, Y Combinator's directory lists it as Inactive (Y Combinator directory entry, November 7, 2017).
Sell to companies like Correlia Biosystems? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Get the full cited report on Correlia Biosystems
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
- The Short Answer
- Warning Bells
- Sources: 1 cited
- See all sections
A Full Report on Correlia Biosystems: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Pitching, partnering or investing alongside them? See who really runs and owns Correlia Biosystems.
Free to see. No signup.
Watch Correlia Biosystems
Get an email when Correlia Biosystems changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Key facts
- · Batch: Winter 2018 · Correlia Biosystems in the Y Combinator directory
- · Industry: Healthcare · Correlia Biosystems in the Y Combinator directory
- · Team size: 16 · Correlia Biosystems in the Y Combinator directory
- · Based: San Francisco · Correlia Biosystems in the Y Combinator directory
- · Status: Inactive, as listed by Y Combinator · Correlia Biosystems in the Y Combinator directory
Correlia Biosystems went through Y Combinator in the Winter 2018 batch, describing itself as Next-gen blood testing to provide 1000x more data to pharma companies. Y Combinator's company directory lists it as Inactive. The directory does not say why a company stopped, and this page does not guess.
- Batch
- Winter 2018
- What they did
- Next-gen blood testing to provide 1000x more data to pharma companies
- Industry
- Healthcare
- Team size
- 16
- Based
- San Francisco
- Status
- Inactive, as listed by Y Combinator
Its batch
Winter 2018 had 146 companies in YC's listing: 77 Active, 29 Acquired, 1 Public and 39 Inactive, so Correlia Biosystems is one of 39 companies from that batch listed as Inactive (27%). Across YC batches at least two years old, 23% of companies are listed Inactive.
Statuses are Y Combinator's own listing in its public company directory, read on the date shown. YC's directory can drop companies altogether, so the Inactive counts here are a floor, not a full count of companies that stopped. Acquired and Public are as YC lists them; neither says anything about the price or the outcome for founders.
The record: Correlia Biosystems in the Y Combinator directory. Measured 2026-11-10 from Y Combinator's company directory.
YC Winter 2018All shut-down YC companiesYC outcomes
Want the whole picture on Correlia Biosystems?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Correlia Biosystems: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Correlia Biosystems covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Tools for this story
Each opens in a new tab, filled in for Correlia Biosystems. With no account yet, you sign up free and land on the result.